Annual Short Term Debt
$728.00 K
-$140.00 K-16.13%
31 December 2023
Summary:
CASI Pharmaceuticals annual short term debt is currently $728.00 thousand, with the most recent change of -$140.00 thousand (-16.13%) on 31 December 2023. During the last 3 years, it has fallen by -$1.50 million (-67.37%). CASI annual short term debt is now -91.49% below its all-time high of $8.56 million, reached on 31 December 2009.CASI Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
N/A
01 September 2024
Summary:
CASI Pharmaceuticals quarterly short term debt is not available.CASI Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CASI Short Term Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -16.1% | - |
3 y3 years | -67.4% | - |
5 y5 years | -51.4% | - |
CASI Short Term Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -67.4% | at low | ||
5 y | 5 years | -67.4% | |||
alltime | all time | -91.5% |
CASI Pharmaceuticals Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Dec 2023 | $728.00 K(-16.1%) | $728.00 K(-16.1%) |
Dec 2022 | $868.00 K(-18.2%) | $868.00 K(-77.9%) |
Sept 2022 | - | $3.92 M(+92.3%) |
June 2022 | - | $2.04 M(+106.2%) |
Mar 2022 | - | $989.00 K(-6.8%) |
Dec 2021 | $1.06 M(-52.4%) | $1.06 M(-2.1%) |
Sept 2021 | - | $1.08 M(-46.2%) |
June 2021 | - | $2.01 M(+1.2%) |
Mar 2021 | - | $1.99 M(-10.8%) |
Dec 2020 | $2.23 M(>+9900.0%) | $2.23 M(>+9900.0%) |
Dec 2019 | $0.00(-100.0%) | $0.00(-100.0%) |
June 2019 | - | $2.65 M(+76.5%) |
Mar 2019 | - | $1.50 M(+0.0%) |
Dec 2018 | $1.50 M(+97.9%) | $1.50 M(-0.0%) |
Sept 2018 | - | $1.50 M(+0.2%) |
Sept 2017 | - | $1.50 M(+0.1%) |
June 2017 | - | $1.50 M(+0.1%) |
Mar 2017 | - | $1.49 M(+0.5%) |
Sept 2016 | - | $1.49 M(+0.5%) |
June 2016 | - | $1.48 M(+0.5%) |
Mar 2016 | - | $1.47 M(+2.6%) |
June 2015 | - | $1.44 M(+1.6%) |
Mar 2015 | - | $1.41 M(-83.3%) |
Mar 2012 | - | $8.44 M(+1013.8%) |
Dec 2010 | $757.50 K(-91.1%) | $757.50 K(-74.6%) |
Sept 2010 | - | $2.98 M(-42.0%) |
June 2010 | - | $5.14 M(-29.0%) |
Mar 2010 | - | $7.24 M(-15.4%) |
Dec 2009 | $8.56 M(+11.0%) | $8.56 M(+11.0%) |
Dec 2008 | $7.71 M | $7.71 M(+2.6%) |
Sept 2008 | - | $7.51 M(+11.5%) |
Date | Annual | Quarterly |
---|---|---|
June 2008 | - | $6.74 M(+39.3%) |
Mar 2008 | - | $4.83 M(+62.1%) |
Dec 2007 | $2.98 M(+297.0%) | $2.98 M(+153.3%) |
Sept 2007 | - | $1.18 M(+259.8%) |
June 2007 | - | $327.20 K(-39.7%) |
Mar 2007 | - | $542.70 K(-27.7%) |
Dec 2006 | $751.10 K(+1131.3%) | $751.10 K(-11.5%) |
Sept 2006 | - | $848.30 K(+3.4%) |
June 2006 | - | $820.40 K(+3.4%) |
Mar 2006 | - | $793.40 K(+1200.7%) |
Dec 2005 | $61.00 K(-98.7%) | $61.00 K(+131.1%) |
Sept 2003 | - | $26.40 K(-51.5%) |
June 2003 | - | $54.40 K(-25.6%) |
Mar 2003 | - | $73.10 K(-98.5%) |
Dec 2002 | $4.87 M(+383.7%) | $4.87 M(+273.8%) |
Sept 2002 | - | $1.30 M(+177.7%) |
June 2002 | - | $468.60 K(-36.7%) |
Mar 2002 | - | $740.50 K(-26.4%) |
Dec 2001 | $1.01 M(+0.9%) | $1.01 M(-6.4%) |
Sept 2001 | - | $1.07 M(+2.5%) |
June 2001 | - | $1.05 M(+2.5%) |
Mar 2001 | - | $1.02 M(+2.5%) |
Dec 2000 | $997.10 K(-11.4%) | $997.10 K(+2.3%) |
Sept 2000 | - | $974.60 K(+2.3%) |
June 2000 | - | $952.50 K(+2.3%) |
Mar 2000 | - | $930.90 K(-17.3%) |
Dec 1999 | $1.13 M(+1025.6%) | $1.13 M(+1025.6%) |
Dec 1996 | $100.00 K | $100.00 K(-50.0%) |
Sept 1996 | - | $200.00 K(-33.3%) |
June 1996 | - | $300.00 K(-25.0%) |
Mar 1996 | - | $400.00 K |
FAQ
- What is CASI Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals annual short term debt year-on-year change?
- What is the all time high quarterly short term debt for CASI Pharmaceuticals?
What is CASI Pharmaceuticals annual short term debt?
The current annual short term debt of CASI is $728.00 K
What is the all time high annual short term debt for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high annual short term debt is $8.56 M
What is CASI Pharmaceuticals annual short term debt year-on-year change?
Over the past year, CASI annual short term debt has changed by -$140.00 K (-16.13%)
What is the all time high quarterly short term debt for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high quarterly short term debt is $8.56 M